CVS Health Corporation (CVS)


NYSE - NYSE Real Time Price. Currency in USD
90.00-0.18 (-0.20%)
As of 12:06 PM EDT. Market open.
People also watch:
COSTRADUNHTGTCL
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open90.02
Prev Close90.18
Bid90.05 x 700
Ask90.06 x 400
Day's Range89.77 - 90.54
52wk Range86.50 - 106.67
1y Target EstN/A
Market Cap95.96B
P/E Ratio (ttm)20.70
Beta0.84
Volume1,738,588
Avg Vol (3m)4,750,539
Dividend & Yield1.70 (1.88%)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Reuters2 hours ago

    U.S. Supreme Court agrees to hear credit card surcharge fee fight

    The U.S. Supreme Court on Thursday agreed to hear a challenge to a New York state law barring retailers from imposing surcharges on customers who make purchases with a credit card rather than cash. The court will hear an appeal filed by a group of merchants to a September 2015 ruling by the New York-based 2nd U.S. Circuit Court of Appeals that upheld the law. Retailers have long complained about the cost of accepting credit cards including "swipe fees," a percentage of a credit card transaction the merchants pay to networks such as MasterCard Inc and Visa Inc every time a credit card is swiped to pay for a purchase.

  • PR Newswire4 hours ago

    CVS Health Expands Access to Opioid Overdose-Reversal Drug for CVS Pharmacy Patients in Five Additional States

    WOONSOCKET, R.I., Sept. 29, 2016 /PRNewswire/ -- CVS Health (NYSE: CVS) today announced it has expanded access to the opioid overdose-reversal drug naloxone in Alabama, Alaska, Illinois, Missouri and West ...

  • Biosimilars in Limelight on FDA Approval of Amgen Drug
    Zacks2 days ago

    Biosimilars in Limelight on FDA Approval of Amgen Drug

    Biosimilars are gaining pace with new approvals and formulary coverage.